Gilead Sciences (GILD) Earnings Date, Estimates & Call Transcripts $92.57 +1.48 (+1.62%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Gilead Sciences Latest Earnings SummaryActual EPS (Nov. 6) $2.02 Beat By $0.44 Consensus EPS (Nov. 6) $1.58 Gilead Sciences posted Q3 2024 earnings on November 6, 2024, reporting an EPS of $2.02, which beat the consensus estimate of $1.58 by $0.44. Quarterly revenue rose 7.0% year-over-year to $7.55 billion, above the consensus estimate of $7.01 billion. With a trailing EPS of $0.09 and a P/E Ratio of 1,028.56, Gilead Sciences' earnings are expected to grow 71.72% next year, from $4.35 to $7.47 per share. Conference CallConference Call TranscriptEarnings Press ReleaseEarnings Slide DeckPowered by Get Gilead Sciences Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Gilead Sciences and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataGILD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.GILD Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Gilead Sciences Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20244-$1.42$1.97$0.94 Q2 20244$1.51$1.98$1.75 Q3 20244$1.58$2.10$1.86 Q4 20244$1.55$1.86$1.75 FY 202416$3.22$7.91$6.31 Q1 20251$1.62$1.62$1.62 Q2 20251$1.72$1.72$1.72 Q3 20251$1.87$1.87$1.87 Q4 20251$1.81$1.81$1.81 FY 20254$7.02$7.02$7.02 Q1 20261$1.55$1.55$1.55 Q2 20261$1.75$1.75$1.75 Q3 20261$2.18$2.18$2.18 Gilead Sciences Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/6/2024Q3 2024$1.58$2.02+$0.44$3.04$7.01B$7.55B8/8/2024Q2 2024$1.61$2.01+$0.40$2.73$6.64B$6.95B4/25/2024Q1 2024-$1.49-$1.32+$0.17$0.70$6.36B$6.69B2/6/2024Q4 2023$1.76$1.72 -$0.04$2.30$7.10B$7.12B11/7/2023Q3 2023$1.91$2.29+$0.38$2.85$6.81B$7.05B8/3/2023Q2 2023$1.64$1.34 -$0.30$1.85$6.45B$6.60B Get the Latest News and Ratings for GILD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gilead Sciences and its competitors with MarketBeat's FREE daily newsletter. 4/27/2023Q1 2023$1.63$1.37 -$0.26$1.94$6.33B$6.35B2/2/2023Q4 2022$1.50$1.67+$0.17$2.04$6.63B$7.39B Gilead Sciences Earnings - Frequently Asked Questions When did Gilead Sciences announce their last quarterly earnings? Gilead Sciences (NASDAQ:GILD) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on GILD's earnings history. What guidance has Gilead Sciences issued on next quarter's earnings? Gilead Sciences updated its FY 2024 earnings guidance on Wednesday, November, 6th. The company provided earnings per share guidance of 4.250-4.450 for the period, compared to the consensus earnings per share estimate of 3.810. The company issued revenue guidance of $27.8 billion-$28.1 billion, compared to the consensus revenue estimate of $27.7 billion. Did Gilead Sciences beat their earnings estimates last quarter? In the previous quarter, Gilead Sciences (NASDAQ:GILD) reported $2.02 earnings per share (EPS) to beat the analysts' consensus estimate of $1.58 by $0.44. Learn more on analysts' earnings estimate vs. GILD's actual earnings. How can I listen to Gilead Sciences's earnings conference call? The conference call for Gilead Sciences's latest earnings report can be listened to online. Listen to Conference Call How can I read Gilead Sciences's conference call transcript? The conference call transcript for Gilead Sciences's latest earnings report can be read online. Read Transcript How much revenue does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded annual revenue of $28.30 billion. How much profit does Gilead Sciences generate each year? Gilead Sciences (NASDAQ:GILD) has a recorded net income of $5.67 billion. GILD has generated $0.09 earnings per share over the last four quarters. What is Gilead Sciences's price-to-earnings ratio? Gilead Sciences (NASDAQ:GILD) has a trailing price-to-earnings ratio of 1,028.56 and a forward price-to-earnings ratio of 21.28. The price/earnings-to-growth ratio is 2.38. What is Gilead Sciences's EPS forecast for next year? Gilead Sciences's earnings are expected to grow from $4.35 per share to $7.47 per share in the next year, which is a 71.72% increase. More Earnings Resources from MarketBeat Related Companies AMGN Earnings Date VRTX Earnings Date REGN Earnings Date ALNY Earnings Date BIIB Earnings Date UTHR Earnings Date INCY Earnings Date NBIX Earnings Date BMRN Earnings Date EXAS Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles History Hints at a Rebound for Toll Brothers After EarningsAlibaba Stock: Why Earnings Make It a Buy Despite the Recent DipMercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of Earnings 2025 could be “worse than the dot-com bust”, says man who predicted 2008 banking crisis (Ad)Dan is sharing his latest work with the public. Because what he's tracking right now, he says, is too serious to keep private.Click here to see Dan's full warning to the public. This page (NASDAQ:GILD) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is ...Brownstone Research | SponsoredThis is the worst sign for the U.S. stock market in 50 yearsThe Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts no...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Gilead Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GILD Stock Alerts